Works about PROGRAMMED cell death 1 receptors

Results: 5000

Recent Advances in Immunotherapy for Melanoma: Perspectives on the Development of Novel Treatments: A Mini Review.

Published in:

Cancers, 2025, v. 17, n. 13, p. 2265, doi. 10.3390/cancers17132265

By:

Muto, Yusuke;
Fujimura, Taku;
Asano, Yoshihide

Publication type:

Article

Tumour- and Non-Tumour-Associated Factors That Modulate Response to PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer.

Published in:

Cancers, 2025, v. 17, n. 13, p. 2199, doi. 10.3390/cancers17132199

By:

Khalil, Maryam;
Tsao, Ming-Sound

Publication type:

Article

Immune Checkpoint Inhibitors for Metastatic Colorectal Cancer: A Systematic Review.

Published in:

Cancers, 2025, v. 17, n. 13, p. 2125, doi. 10.3390/cancers17132125

By:

Gilson, Alice;
Tan, Vincent;
Koessler, Thibaud;
Meyer, Jeremy;
Meurette, Guillaume;
Liot, Émilie;
Ris, Frédéric;
Delaune, Vaihere

Publication type:

Article

Subclassification-Specific Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Implications for Appropriate Pharmacotherapy.

Published in:

Cancers, 2025, v. 17, n. 13, p. 2082, doi. 10.3390/cancers17132082

By:

Kinoshita, Masahiko;
Sato, Yasunori;
Kubo, Shoji;
Shinkawa, Hiroji;
Kimura, Kenjiro;
Nishio, Kohei;
Tanaka, Ryota;
Kurihara, Shigeaki;
Ishizawa, Takeaki

Publication type:

Article

Focus on PD-1/PD-L1-Targeting Antibodies in Colorectal Cancer: Are There Options Beyond Dostarlimab, Nivolumab, and Pembrolizumab? A Comprehensive Review.

Published in:

Molecules, 2025, v. 30, n. 13, p. 2686, doi. 10.3390/molecules30132686

By:

Kciuk, Mateusz;
Wanke, Katarzyna;
Kruczkowska, Weronika;
Marciniak, Beata;
Kontek, Renata

Publication type:

Article

BST2 and DIRAS3 Drive Immune Evasion and Tumor Progression in High-Grade Glioma.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 13, p. 6205, doi. 10.3390/ijms26136205

By:

Liao, Zhangjun;
Wu, Shuyi;
Shi, Zhenyi;
Chen, Donghui;
Chen, Jinrui;
Zhang, Hua

Publication type:

Article

Membrane-spanning 4 domains subfamily A member 4A inhibition promotes M1 macrophage polarization and enhances anti-gastric cancer immune response.

Published in:

CytoJournal, 2025, v. 22, p. 1, doi. 10.25259/Cytojournal_271_2024

By:

Zhang, Xinyue;
Na, Di

Publication type:

Article

PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Chinese patients with advanced non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized controlled trials.

Published in:

World Journal of Surgical Oncology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12957-025-03934-8

By:

Zhang, Jianfei;
Liu, Min;
Li, Dongyang;
Luo, Jiali;
Wang, Min

Publication type:

Article

The Potential of ESCO2 as a Prognostic and Immunotherapeutic Marker of Pan-Cancer and Its Role in Anti-PD-1 Treatment of Bladder Cancer.

Published in:

Oncology, 2025, v. 103, n. 7, p. 610, doi. 10.1159/000542188

By:

Guo, Wei;
Zhao, Shuo;
Yan, Keqiang;
Fan, Yidong;
Liu, Jikai

Publication type:

Article

Combined PD-1 and CTLA-4 Blockade Increases the Risks of Multiple Pituitary Hormone Deficiency and Isolated Adrenocorticotropic Deficiency: A Prospective Study.

Published in:

Endocrinology & Metabolism, 2025, v. 40, n. 3, p. 459, doi. 10.3803/EnM.2024.2180

By:

Shintaro Iwama;
Tomoko Kobayashi;
Tetsushi Izuchi;
Koji Suzuki;
Takanori Murase;
Masahiko Ando;
Tomoko Handa;
Takeshi Onoue;
Takashi Miyata;
Mariko Sugiyama;
Daisuke Hagiwara;
Hidetaka Suga;
Ryoichi Banno;
Tetsunari Hase;
Shoichiro Mori;
Tomoyasu Sano;
Shusuke Akamatsu;
Masashi Akiyama;
Makoto Ishii;
Hiroshi Arima

Publication type:

Article

Clinicopathologic and prognosis of 30 patients with FH-deficient renal cell carcinoma: a single-center retrospective study.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14562-6

By:

Bai, Junjie;
Huang, Jianjia;
Ye, Yushi;
Lin, Jun;
Wen, Yahui;
Cai, Zicheng;
Chen, Peihuang;
Shangguan, Tong;
Zou, Gaoyu;
Qiu, Qianyi;
Chen, Ru;
Liu, Rong;
Cai, Weizhong;
Zhu, Shaoxing;
Chen, Jianhui;
Li, Xiaoyan

Publication type:

Article

Correction to: Cancer-associated fibroblasts and metabolic reprogramming predict pathologic response to neoadjuvant PD-1 blockade in resected non-small cell lung cancer.

Published in:

2025

By:

Zhao, Jiaqi;
Liu, Maolin;
Zhu, Chongmei;
Li, Zhuolin;
Liu, Zuhui;
Abulizi, Dilimulati;
Liu, Siqing;
Wang, Xin;
Yang, Haoxian;
Hou, Xue

Publication type:

Correction Notice

Programmed Death Ligand 1 Modulation by Bacillus Calmette-Guérin and Toll-Like Receptor Agonists in Distinct Breast Cancer Cell Subtypes.

Published in:

International Journal of General Medicine, 2025, v. 18, p. 3401, doi. 10.2147/IJGM.S531858

By:

Barbosa, Gabriela;
Godoy, Maria Carolina Ximenes De;
Bighetto, Caroline Cavalli;
Skakum, Emily Macedo;
Pascoal, Lívia Bitencourt;
Gambero, Alessandra;
Reis, Leonardo O

Publication type:

Article

Efficacy of dostarlimab in recurrent or advanced mismatch Repair-Deficient endometrial Cancer as a Single-Agent therapy: A systematic review and Meta-Analysis.

Published in:

DARU: Journal of Pharmaceutical Sciences, 2025, v. 33, n. 2, p. 1, doi. 10.1007/s40199-025-00564-z

By:

Rezaei, Ramazan;
Khani, Hedieh Haji Khodaverdi

Publication type:

Article

PD-L1 Expression and Tumor Microenvironment Dynamics in Diffuse Large B-Cell Lymphoma: Immunophenotypic Insights.

Published in:

Journal of Medicine & Life, 2025, v. 18, n. 5, p. 463, doi. 10.25122/jml-2025-0078

By:

Halcu, Georgian;
Mureșan, Filip Cristian;
Niculae, Andrei;
Evsei-Seceleanu, Anca;
Lapadat, Mihai-Emilian;
Cerbu, Mihai Adrian;
Ceausu, Mihail

Publication type:

Article

Total neoadjuvant immunochemotherapy for proficient mismatch repair or microsatellite stable locally advanced rectal cancer.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1611386

By:

Li, Xing;
Tang, Ligong;
Cheng, Fangyuan;
Xu, Yongchao

Publication type:

Article

Association of the combined parameters including the frequency of primary cilia, PD-L1, Smoothened protein, membranous ß-catenin and cytoplasmic ß-catenin expression with the outcome of patients with clear cell renal cell carcinoma.

Published in:

Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 2025, v. 169, n. 2, p. 107, doi. 10.5507/bp.2024.005

By:

Rozsypalova, Aneta;
Rosova, Blanka;
Filipova, Alzbeta;
Nikolov, Dimitar Hadzi;
Chloupkova, Renata;
Richter, Igor;
Zachoval, Roman;
Matej, Radoslav;
Melichar, Bohuslav;
Buchler, Tomas;
Dvorak, Josef

Publication type:

Article

Skin Reactions as a Prognostic Factor in Immunotherapy of Non-Small Cell Lung Cancer.

Published in:

International Medical Journal, 2025, v. 32, n. 2, p. 97

By:

Kolasa, Eliza;
Paluch, Alicja;
Koźlicka, Aleksandra;
Szklener, Katarzyna

Publication type:

Article

Characterization and functional evaluation of JS207, a novel bispecific antibody against human PD-1 and VEGFA.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1612547

By:

Lin, Shihua;
Hong, Min;
Zhang, Jing;
Zhao, Wenting;
Li, Ke;
Wu, Chun;
Yang, Qiuyun;
Xiao, Yi;
Huang, Lanqing;
Wang, Jing;
Jia, Aijuan;
Wang, Xujia;
Yao, Sheng

Publication type:

Article

The responses of HNSCC patients to immunotherapy are shown by two novel co-expression patterns.

Published in:

NPJ Precision Oncology, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41698-025-00983-w

By:

Daher-Ghanem, Narmeen;
Sharon, Shay;
Tao, Derrick;
Sun, Zhaoyu;
Rosales, Wesley;
Rajamanickam, Venkatesh;
Meng, Ryan;
Kaur, Lakhvir;
Bernard, Brady;
Piening, Brian;
Couey, Marcus;
Gough, Michael J.;
Kravchenko-Balasha, Nataly

Publication type:

Article

Exploring new avenues in non--muscle-invasive bladder cancer treatment.

Published in:: 2025
Publication type:: Conference Paper/Materials

Structure–activity relationship of <sup>18</sup>F-labeled PD-L1-targeting small molecule ligands: impact of radiolabeling strategy on affinity and in vivo performance.

Published in:

EJNMMI Radiopharmacy & Chemistry, 2025, v. 10, n. 1, p. 1, doi. 10.1186/s41181-025-00359-2

By:

Krutzek, Fabian;
Donat, Cornelius K.;
Stadlbauer, Sven

Publication type:

Article

Evaluation of polymorphism in BCL-2, PD-1, and PD-L1 genes in myelodysplastic neoplasms.

Published in:

Acta Haematologica Polonica, 2025, v. 56, n. 3, p. 222, doi. 10.5603/ahp.104373

By:

Kuszczak, Bartłomiej;
Łacina, Piotr;
Dratwa-Kuzmin, Marta;
Bogunia-Kubik, Katarzyna;
Wróbel, Tomasz;
Rybka, Justyna

Publication type:

Article

Increased mucosal and T-cell expression of 4-1BB and PD-1 are modulated by anti-TNFα treatment in Crohn's disease.

Published in:

Scandinavian Journal of Gastroenterology, 2025, v. 60, n. 7, p. 698, doi. 10.1080/00365521.2025.2505622

By:

Nielsen, Morten Aagaard;
Bendix, Mia;
Hvas, Christian Lodberg;
Deleuran, Bent;
Reinert, Line S.;
Agnholt, Jørgen;
Dige, Anders

Publication type:

Article

Neoadjuvant chemoradiotherapy with or without PD-1/PD-L1 inhibitors in locally advanced rectal cancer: a systematic review and meta-analysis.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14482-5

By:

Ansab, Muhammad;
Razi, Sepideh;
Nisa, Farwa;
Araib, Eiman;
Rath, Shree;
Khan, Iqra;
Ramzan, Noor Ul Huda;
Dilawar, Esha;
Saeed, Anwaar

Publication type:

Article

Efficacy and safety outcomes of PD-1/PD-L1 inhibitors in recurrent cholangiocarcinoma: a real-world, multicenter and retrospective study.

Published in:

BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14459-4

By:

Lin, Lihui;
Lin, Yansong;
Chen, Wei;
Yang, Xia;
Guo, Xianwen;
Wu, Yanqin;
Yin, Xiaoyu;
Ding, Zhen;
Yun, Jingping

Publication type:

Article

Deciphering cardiotoxicity in PD-1/PD-L1 inhibitor treatment.

Published in:

Central European Journal of Immunology, 2025, v. 50, n. 1, p. 2, doi. 10.5114/ceji.2025.151335

By:

Tabarkiewicz, Jacek;
Głodkowska-Mrówka, Eliza;
Eljaszewicz, Andrzej

Publication type:

Article

PD-1/PD-L1 inhibitor treatment associated with cardiotoxicity regulated by macrophage polarization and SOCS3/JAK/STAT3 signaling pathway.

Published in:

Central European Journal of Immunology, 2025, v. 50, n. 1, p. 24, doi. 10.5114/ceji.2025.149377

By:

Fu, Jiding;
Wang, Ge;
Zeng, Lisi;
Lin, Jie;
Wei, Yier;
Xu, Wei;
Xu, Rui;
Xian, Lewu

Publication type:

Article

5‐ALA Assisted Surgery of Human Glioblastoma Samples Reveals an Enrichment of T Cells Expressing PD‐1 and CD103 in the Intermediate and Marginal Layers.

Published in:

European Journal of Immunology, 2025, v. 55, n. 6, p. 1, doi. 10.1002/eji.202451681

By:

Vanni, Anna;
Matani, Francesca;
Bonaudo, Camilla;
Mazzoni, Alessio;
Capone, Manuela;
Lamacchia, Giulia;
Salvati, Lorenzo;
Bartoli, Lucia;
Francalanci, Stefania;
Petti, Mirko;
Capelli, Federico;
Nozzoli, Filippo;
Cosmi, Lorenzo;
Liotta, Francesco;
Della Puppa, Alessandro;
Maggi, Laura;
Annunziato, Francesco

Publication type:

Article

Advances and challenges in cancer immunotherapy: mechanisms, clinical applications, and future directions.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1602529

By:

Vatsavai, Neeharika;
Kaur Bhinder, Sumeet;
Shaik, Rahaman;
Mahira, Shaheen;
Kapoor, Shruti;
Ali, Md Shadab;
Verma, Deepak;
Singh, Jay;
Badavenkatappa Gari, Sreelakshmi;
Upadhyay, Prabhat;
Meshkovska, Yeva;
Godugu, Chandraiah;
Thatikonda, Sowjanya;
Pooladanda, Venkatesh

Publication type:

Article

PD-1/PD-L1 inhibitor-induced hyponatremia: a real-world pharmacovigilance analysis using FAERS database.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1561942

By:

Tao, Chao;
Liu, Bingyao;
Dai, Yan;
Lv, Jinyi;
He, Huanhuan;
Ding, Qian;
Chen, Kun;
Wang, Ke;
Yang, Liuxuan;
Ren, Xiaoqun;
Zhou, Meiling

Publication type:

Article

A Chemoinformatics Investigation of Spectral and Quantum Chemistry Patterns for Discovering New Drug Leads from Natural Products Targeting the PD-1/PD-L1 Immune Checkpoint, with a Particular Focus on Naturally Occurring Marine Products.

Published in:

Marine Drugs, 2025, v. 23, n. 6, p. 247, doi. 10.3390/md23060247

By:

Rabelo, Henrique;
Tsimiante, Ayana;
Binev, Yuri;
Pereira, Florbela

Publication type:

Article

Immune-Checkpoint Expression in Breast Cancer Patients: Clinicopathological Implications: A Retrospective Case Series Study.

Published in:

2025

By:

Quiroz-Bolaños, Angel;
Quintero-Ramos, Antonio;
Godínez-Rubí, Juliana Marisol;
Franco-Topete, Ramon;
González, Porfirio Gutiérrez;
Gutiérrez-Zepeda, Bricia M.;
Becerra-Loaiza, Denisse S.;
Topete, Antonio;
de Loera-Rodriguez, Cesar;
Toro-Arreola, Alicia Del;
Daneri-Navarro, Adrián

Publication type:

Case Study

The role of tumor-associated macrophages and PD-1/PD-L1 networking in colorectal cancer.

Published in:

Contemporary Oncology / Współczesna Onkologia, 2025, v. 29, n. 2, p. 123, doi. 10.5114/wo.2025.150448

By:

Yerolatsite, Melina;
Torounidou, Nanteznta;
Amylidi, Anna-Lea;
Zarkavelis, George;
Hadjigeorgiou, Loizos;
Lampri, Evangeli;
Bali, Christina;
Georvasili, Vaia;
Kampletsas, Eleftherios;
Mauri, Davide

Publication type:

Article

The distribution characteristics of PD-1 pathway-related immune cells in esophageal cancer tissue and their prognostic significance.

Published in:

PLoS ONE, 2025, v. 20, n. 6, p. 1, doi. 10.1371/journal.pone.0325349

By:

Kong, Dehua;
Gao, Chunyan;
Yu, Yang;
Yang, Lu;
Ma, Ji;
Tang, Shimin;
Mao, Ying;
Li, Yong;
Li, Na

Publication type:

Article

Genome‐Wide Aggregated Trans Effects Analysis Identifies Genes Encoding Immune Checkpoints as Core Genes for Rheumatoid Arthritis.

Published in:

Arthritis & Rheumatology, 2025, v. 77, n. 7, p. 817, doi. 10.1002/art.43125

By:

Spiliopoulou, Athina;
Iakovliev, Andrii;
Plant, Darren;
Sutcliffe, Megan;
Sharma, Seema;
Cubuk, Cankut;
Lewis, Myles;
Pitzalis, Costantino;
Barton, Anne;
McKeigue, Paul M.

Publication type:

Article

Mini‐review: Immunology in ovarian cancer.

Published in:

Journal of Obstetrics & Gynaecology Research, 2023, v. 49, n. 9, p. 2245, doi. 10.1111/jog.15730

By:

Taki, Mana

Publication type:

Article

Comprehensive analysis of the immunological landscape of pituitary adenomas: implications of immunotherapy for pituitary adenomas.

Published in:

Journal of Neuro-Oncology, 2020, v. 149, n. 3, p. 473, doi. 10.1007/s11060-020-03636-z

By:

Zhou, Wenjianlong;
Zhang, Chuanbao;
Zhang, Dainan;
Peng, Jiayi;
Ma, Shunchang;
Wang, Xi;
Guan, Xiudong;
Li, Peiliang;
Li, Deling;
Jia, Guijun;
Jia, Wang

Publication type:

Article

Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition.

Published in:

Journal of Neuro-Oncology, 2020, v. 149, n. 1, p. 13, doi. 10.1007/s11060-020-03580-y

By:

Jiménez, Isabel;
Carabia, Júlia;
Bobillo, Sabela;
Palacio, Carles;
Abrisqueta, Pau;
Pagès, Carlota;
Nieto, Juan C.;
Castellví, Josep;
Martínez-Ricarte, Francisco;
Escoda, Lourdes;
Perla, Cristóbal;
Céspedes Torrez, Dennis H.;
Boix, Joan;
Purroy, Noelia;
Puigdefàbregas, Lluís;
Seoane, Joan;
Bosch, Francesc;
Crespo, Marta

Publication type:

Article

PD-1/PD-L1 and immune-related gene expression pattern in pediatric malignant brain tumors: clinical correlation with survival data in Korean population.

Published in:

Journal of Neuro-Oncology, 2018, v. 139, n. 2, p. 281, doi. 10.1007/s11060-018-2886-5

By:

Hwang, Kihwan;
Koh, Eun Jung;
Choi, Eun Jin;
Kang, Tae Hee;
Han, Jung Ho;
Choe, Gheeyoung;
Park, Sung-Hye;
Yearley, Jennifer Holmes;
Annamalai, Lakshmanan;
Blumenschein, Wendy;
Sathe, Manjiri;
Mcclanahan, Terri;
Jung, Hun;
Wang, Kyu-Chang;
Kim, Seung-Ki;
Kim, Chae-Yong

Publication type:

Article

The expression profile of PD-L1 and CD8<sup>+</sup> lymphocyte in pituitary adenomas indicating for immunotherapy.

Published in:

Journal of Neuro-Oncology, 2018, v. 139, n. 1, p. 89, doi. 10.1007/s11060-018-2844-2

By:

Wang, Peng-fei;
Wang, Ting-jian;
Yang, Ya-kun;
Yao, Kun;
Li, Zhuo;
Li, Yan Michael;
Yan, Chang-Xiang

Publication type:

Article

Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.

Published in:

Journal of Neuro-Oncology, 2017, v. 133, n. 3, p. 595, doi. 10.1007/s11060-017-2470-4

By:

Fang, Penny;
Jiang, Wen;
Allen, Pamela;
Glitza, Isabella;
Guha, Nandita;
Hwu, Patrick;
Ghia, Amol;
Phan, Jack;
Mahajan, Anita;
Tawbi, Hussein;
Li, Jing

Publication type:

Article

Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment.

Published in:

2016

By:

Mathios, Dimitrios;
Ruzevick, Jacob;
Jackson, Christopher;
Xu, Haiying;
Shah, Sagar;
Taube, Janis;
Burger, Peter;
McCarthy, Edward;
Quinones-Hinojosa, Alfredo;
Pardoll, Drew;
Lim, Michael

Publication type:

Erratum

Retraction Note: miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1.

Published in:

2023

By:

Wang, Yi;
Wang, Li

Publication type:

Correction Notice

BMSCs improve TNBS-induced colitis in rats by inducing Treg differentiation by expressing PD-L1.

Published in:

Biotechnology Letters, 2022, v. 44, n. 11, p. 1263, doi. 10.1007/s10529-022-03307-1

By:

Gao, Fei;
Cui, Dandan;
Zuo, Dongmei;
Shou, Zhexing;
Yang, Jia;
Yu, Ting;
Liu, Yujin;
Chu, Si;
Zhu, Feng;
Wei, Chunzhu

Publication type:

Article

Nanobody against PDL1.

Published in:

Biotechnology Letters, 2020, v. 42, n. 5, p. 727, doi. 10.1007/s10529-020-02823-2

By:

Li, Shufeng;
Jiang, Kunpeng;
Wang, Ting;
Zhang, Wei;
Shi, Minke;
Chen, Baojun;
Hua, Zichun

Publication type:

Article

Hsp90 up-regulates PD-L1 to promote HPV-positive cervical cancer via HER2/PI3K/AKT pathway.

Published in:

Molecular Medicine, 2021, v. 27, n. 1, p. 1, doi. 10.1186/s10020-021-00384-2

By:

Zeng, Jie;
He, Si-Li;
Li, Li-Jie;
Wang, Chen

Publication type:

Article

Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer.

Published in:

Molecular Medicine, 2020, v. 26, n. 1, p. 1, doi. 10.1186/s10020-020-00208-9

By:

Sun, Dantong;
Tian, Lu;
Zhu, Yan;
Wo, Yang;
Liu, Qiaoling;
Liu, Shihai;
Li, Hong;
Hou, Helei

Publication type:

Article

Serpin family H member 1 and its related collagen gene network are the potential prognostic biomarkers and anticancer targets for glioma.

Published in:

Journal of Biochemical & Molecular Toxicology, 2024, v. 38, n. 1, p. 1, doi. 10.1002/jbt.23541

By:

Wang, Qi;
Wang, Zhe

Publication type:

Article

Synergistic effects of BTN3A1, SHP2, CD274, and STAT3 gene polymorphisms on the risk of systemic lupus erythematosus: a multifactorial dimensional reduction analysis.

Published in:

Clinical Rheumatology, 2024, v. 43, n. 1, p. 489, doi. 10.1007/s10067-023-06765-8

By:

Tang, Yang-Yang;
Xu, Wang-Dong;
Fu, Lu;
Liu, Xiao-Yan;
Huang, An-Fang

Publication type:

Article